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A B S T R A C T
During a serological survey, 157 out of 681 unvaccinated buﬀaloes resulted seropositive for bovine alpha-
herpesvirus 1 (BoHV1) glycoprotein B (gB) and seronegative for BoHV1 glycoprotein E (gE). These serological
results were generally expected in animals vaccinated with a BoHV1 gE-deleted vaccine but not in unvaccinated
animals. Seroneutralization tests on 36 selected sera detected neutralizing antibody titers more than three times
higher for BuHV1 than for BoHV1. In order to investigate the virus, one of these buﬀaloes was injected with
dexamethasone, and from nasal and vaginal swabs collected at diﬀerent time points, a ruminant herpesvirus was
isolated, characterized and also detected by PCR. Restriction enzyme analysis, sequencing and phylogenic
analysis of gB and gD genes showed that the virus was genetically similar but not identical to BuHV1 strain b6.
Intranasal inoculation of the virus in a healthy seronegative buﬀalo resulted in a mild and transient upper
respiratory disease; the virus was isolated from clinical specimens and DNA was detected by PCR in nasal and
vaginal swabs up to 9 days after infection. Further investigations should be aimed at sequencing the whole viral
genome and at evaluating the host-range of this virus. Speciﬁc tests are needed to discriminate infections by
diﬀerent ruminant herpesviruses and to improve eradication programs of infectious bovine rhinotracheitis/in-
fectious pustular vulvovaginitis in cattle.
1. Introduction
Herpesviruses are DNA viruses characterized by a capacity to induce
latent infection. Among alphaherpesviruses infecting ruminants, the
prototype is Bovine alphaherpesvirus 1 (BoHV1), a pathogen of cattle
associated mainly with infectious bovine rhinotracheitis (IBR) and in-
fectious pustular vulvovaginitis (IPV). In addition, several alpha-
herpesviruses related to BoHV1 have been isolated and characterized in
domestic and wild ruminants, showing usually low virulence (Thiry
et al., 2006 and 2007). In Italy, water buﬀalo breeding is consistent,
especially in South and Central regions because of typical production,
like buﬀalo Mozzarella cheese. Mixed breeding of cattle and buﬀalo
also exists. However, a Bubaline alphaherpesvirus 1 (BuHV1) has been
found in a water buﬀalo fetus associated with abortion in Italy
(Amoroso et al., 2013). Further investigations in Italy showed a high
seroprevalence for BuHV1 in Piedmont (Northern Italy) and Campania
(Southern Italy) regions, where IBR control programs have been im-
plemented (Caruso et al., 2016). In order to enable control and eradi-
cation of IBR diseases in the European Union, rules for the intra-
Community movement of bovine animals have been implemented. Al-
though control measures should be directed to the eradication of the
infection rather than to the suppression of disease, the use of gE-deleted
BoHV1 vaccines is allowed in bovine animals (Decision 2004/558/CE).
The use of DIVA (Diﬀerentiating Infected from Vaccinated Animals)
vaccines is favored because they do not interfere with eradication
programs based on detection of infected animals. In this case, gB- and
gE-seropositive animals are considered infected with BoHV1, while gB-
positive and gE-negative animals are considered vaccinated with a gE-
deleted vaccine. However, eradication programs could fail if animals
are infected by a gE-positive BuHV1 causing interference in the inter-
pretation of test results.
This paper describes the case occurred in a buﬀalo farm never
vaccinated with a gE-deleted BoHV1 vaccine but resulted seropositive
for anti-BoHV1 gB antibodies and seronegative for anti-gE antibodies.
The aims of this study were i) to investigate the cause of these ser-
ological results by isolation and characterization of the virus from a gB-
positive/gE-negative buﬀalo and ii) to evaluate the virulence and the
kinetic of viral excretion in a seronegative experimentally infected
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buﬀalo.
2. Materials and methods
2.1. Serological screening
Sera samples were collected for an epidemiological survey from 681
buﬀaloes reared in 8 diﬀerent herds in Central Italy. The animals were
not vaccinated for BoHV1 and gE deleted BoHV1 vaccine had been
never used in these farms. Sera were tested by two commercial blocking
ELISA tests to detect antibodies anti-BoHV1-gB and anti-BoHV1-gE (IBR
gB/gE IDEXX Herd Check Laboratories). BoHV1 infected animals are
supposed to be positive to both tests, uninfected animals are supposed
to be negative to both tests, and animals vaccinated with a BoHV1-gE-
deleted vaccine are supposed to be seropositive for gB but seronegative
for gE. The serological tests were carried out following the manu-
facturer’s instructions.
On the basis of the ELISA results, selected sera were subsequently
tested by seroneutralization to detect anti-BuHV1 and anti-BoHV1 an-
tibodies.
2.2. Seroneutralization test
Seroneutralization test was performed as follows. Each sample was
diluted 1:2 in minimal essential medium (MEM) containing 10% fetal
bovine serum and two-fold serial dilutions of sera in MEM were in-
cubated in sterile 96-well microtitre plates for 1 h at 37 °C with an equal
volume of the diluted virus (100–200 TCID50 of BoHV1 LA strain
(Castrucci et al., 1984)). All sera were incubated separately with BuHV1
and with BoHV1. Approximately 1.5×104 MDBK cells were added to
each well and the plates were incubated for 3–5 days at 37 °C in a
humid atmosphere of 5% CO2 in air. Plates were checked and read
daily. Final reading was performed the 5th day. The results were ex-
pressed as the reciprocal of the dilution of the serum that neutralized
the virus in 50% of the wells. Positive and negative control sera and
controls for the cell viability, BuHV1 and BoHV1 infectivity, and test
serum cytotoxicity were included in each assay. The control immune
sera used for the seroneutralization test were obtained from one buﬀalo
and from one cattle inoculated respectively with BuHV1 and with
BoHV1.
2.3. Virus reactivation and isolation
In order to reactivate the herpesvirus from latency, the buﬀalo ID
810 was selected, on the basis of seroneutralization results, for phar-
macological treatment similarly as previously reported (De Carlo et al.,
2004). In particular, sodium dexamethasone-21-phosphate (Desashock,
Fort Dodge Animal Health) at a dosage of 4mg/kg body weight was
injected intramuscularly daily for ﬁve days (from day 1 to day 5). Nasal
and vaginal swabs were collected daily for 11 days (from day 5 to day
15) for viral isolation and PCR. Immediately after sampling, the swabs
collected for viral isolation were put in a tube with MEM, while swabs
collected for PCR analysis were transported in tubes without MEM.
Once arrived in the laboratory, samples in MEM were ﬁltered (0.45 μm)
and 100 μl inoculated into each well of 24-well plates containing con-
ﬂuent MDBK cell cultures. The plates were incubated at 37 °C in mod-
iﬁed atmosphere with 5% CO2 and daily checked for cytopathic eﬀects.
Seven days after inoculation, the monolayer was frozen and thawed,
and the supernatant was inoculated in another plate containing a MDBK
monolayer up to a total of three passages. MDBK cultures showing
cytopathic eﬀects were tested by PCR. The virus isolate was named
IT08M134.
2.4. DNA extraction and PCR
DNA was extracted from 100 μl cell cultures and from all nasal and
vaginal swabs by using the commercial kit Genomic DNA isolation kit
(Norgen Biotek Corp., Thorold, ON, Canada) following the manu-
facturer’s instructions and eluting the DNA in 100 μl ﬁnal volume. DNA
was also obtained from cell cultures infected with BoHV1 strain Cooper,
which has been used as positive control.
PCR with primers CR30 and CR31 were used to amplify and se-
quence a 444 bp region of the gB gene (UL27) of all ruminant alpha-
herpesviruses related to BoHV1 (Ros and Belák, 1999). Further PCRs
were carried out to detect and sequence genes codifying for the gD
(primers CR52/CR54) (Ros and Belák, 1999; De Carlo et al., 2004), gB
(gB-1/gB-2 and gBN-1/gBN-2), gC (gC-1/gC-2) and gE (gE-1/gE-2 and
gEN-1/gEN-2) of BoHV1 (Fuchs et al., 1999).
PCRs were carried out in 100 μl ﬁnal volume containing 50 μl of Taq
PCR mastermix (Qiagen, Germany), 50 pmol of the forward and of the
reverse primers, and 2 μl of DNA. The mixture for the nested PCR was
the same but products of the ﬁrst PCRs were used as a template. PCR
grade water instead of DNA was used as a negative control. PCRs with
gE-1/gE-2 primers and gEN-1/gEN-2 primers were carried out with and
without addition of 5% (vol/vol) dimethyl sulfoxide. The ampliﬁcation
programs consisted of 95 °C for 5m, 35 cycles of 95 °C for 1m, 52 °C
(primers CR52/CR54) or 60 °C (primers CR30/CR31) for 1m, 72 °C for
1m, and ﬁnal extension at 72 °C for 7m. PCRs for the gB, gC and gE
genes were carried out as previously described (Fuchs et al., 1999), but
separate single reactions instead of a multiplex PCR reaction in order to
sequence the products obtained were performed.
Both ﬁrst and second reaction products were analyzed by electro-
phoresis of 10 μl of reaction products in 1.5% agarose gels containing
0.5 mg/ml of ethidium bromide with Tris-borate-EDTA buﬀer (89mM
Tris, 89mM boric acid, 2 mM EDTA pH: 8.3). Images were visualized on
a UV transluminator and captured by the Kodak Gel Logic 100 system.
2.5. Restriction enzyme analysis (REA)
Viral DNA obtained by a cell culture with cytopathic eﬀects and
positive by PCR was submitted to BamHI and BstEII restriction en-
donucleases (New England Biolabs, England, United Kingdom) (Thiry
et al., 2007). The digestion products were electrophoresed in a 0.7%
Tris Acetate EDTA agarose gel for 18 h at 50 V/cm and 500mA.
SmartLadder (10 kb; Eurogentec, Liège, Belgium) as molecular mass
marker was used. DNA of other ruminant alphaherpesviruses was used
as control (Thiry et al., 2007).
2.6. Sequencing of the PCR products and phylogenetic analysis
PCR products obtained by primers gB-1/gB-2, CR30/CR31 and
CR52/CR54 were treated with ExoSAP-IT and were sequenced on both
strands by an external laboratory (BMR Genomics, Padua, Italy).
Primers gB-1/gB-2 and CR30/CR31 bind the UL27 sequence of BuHV1
strain b6 (KU936049.1) at positions 56932-56951/57390-57409 and
56707-56726/57130-57150 respectively and amplify two segments
which partially overlap each other. The sequences obtained were vi-
sually checked and were analyzed by NIH BLAST. All sequences of the
UL27 gene (encoding the glycoprotein B) and of the UL6 gene (en-
coding for the gD) of ruminant herpesviruses available in GenBank and
EMBL were downloaded and aligned with the sequences obtained in our
study. Sequences were aligned using Clustal X (Larkin et al., 2007) and
manual editing was performed with BioEdit version 7.2.5 (Hall, 1999).
MEGA version 7.0 was used to select the simplest evolutionary model
that adequately ﬁtted the sequence data (Kumar et al., 2016). The
model with the lowest Bayesian Information Criterion (BIC) was con-
sidered to describe the substitution pattern the best. On the basis of the
BIC values obtained, the model Tamura-3 parameter with a discrete
Gamma distribution (+G) with 5 parameters was used (Tamura, 1992).
The neighbor-joining algorithm (NJ) and the maximum likelihood (ML)
method were estimated for phylogeny. In both analyses, 1000 bootstrap
replicates were used.
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2.7. Virus inoculation in a seronegative buﬀalo
A female buﬀalo resulted seronegative for BoHV1 and for BuHV1 at
three tests performed weekly was selected for experimental infection
with the virus IT08M134. The buﬀalo was kept separately from other
animals and was clinically monitored for seven days. At T0 serum, nasal
and vaginal swabs were collected from the buﬀalo, which was subse-
quently infected by the nasal route with 1ml/nostril of viral suspension
(titer 106.5/100 μl).
The animal was clinically examined and the body temperature was
recorded daily for 21 days. Nasal and vaginal swabs were collected
daily for 21 days for viral isolation and for PCR. On the basis of pre-
liminary comparative evaluations, nested PCR with primers gB-1/gB-2
and gBN-1/gBN-2 for detecting the gB gene showed higher sensitivity
than the other PCRs and was used for testing these samples (data not
showed). However, the PCR protocol was optimized in order to max-
imize its sensitivity. In particular, the new protocol consisted of 95 °C
for 5m, 35 cycles of 95 °C for 1m, 69 °C (primers gB-1/gB-2) or 55 °C
(primers gBN-1/gBN-2) for 1m, 72 °C for 1m, and ﬁnal extension at
72 °C for 7m. Blood sera were collected weakly for seroneutralization
tests.
3. Results
3.1. Serological screening and seroneutralization tests
A total of 555 out of 681 sera (81.5%) resulted positive for anti-gB
antibodies, 102 (15.0%) were negative and 24 (3.5%) were doubtful.
Out of the 555 anti-gB positive sera, 157 (28.3%) were negative for
anti-gE antibodies, 355 (64.0%) were gE-positive and 43 (7.7%) were
doubtful. All 8 farms had at least one animal with anti-gB antibodies.
Randomly selected sera resulted gB-positive and gE-positive
(n=10), gB-positive and gE-doubtful (n= 10), gB-positive and gE-
negative (n=10), gB-negative and gE-positive (n= 3), gB-negative
and gE-doubtful (n= 3) were tested by seroneutralization tests.
All sera gB-positive and gE-positive, all sera gB-positive and gE-
doubtful and all but two sera gB-positive and gE-negative showed
neutralizing antibody titers more than three times higher for BuHV1
than for BoHV1 (Table 1). All gB-negative and gE-doubtful sera and 2
out of 3 gB-negative and gE-positive sera did show neutralizing anti-
bodies against neither BoHV1 nor BuHV1, while one serum showed
titers more than three times higher for BuHV1 than for BoHV1.
3.2. Virus reactivation, isolation and PCR
After treatment with sodium dexamethasone-21-phosphate, the in-
fected buﬀalo showed fever, clear ocular and nasal discharge, mild
cough and dyspnea.
Cytopathic eﬀects suggestive of herpesvirus infection were observed
in cell cultures inoculated with nasal and vaginal swabs. Results of viral
isolation and nested PCR obtained from infected cell culture as well as
nasal and vaginal swabs collected from 5 to 15 days after glucocorticoid
treatment are reported in Table 2. Nested PCR results were positive
with primers gB-1/gB-2 and gBN-1/gBN-2 but not with primers gE-1/
gE-2 and gEN-1/gEN-2.
3.3. Restriction enzyme analysis (REA) on viral DNA
REA tests demonstrated that the isolate IT08M134 was genetically
similar but not identical to BuHV1 b6 and distinct from BoHV1 (1.1
Lam and 1.2a K22) (Fig. 1). Its REA pattern was also distinct from the
other related ruminant alphaherpesviruses namely BoHV1, caprine al-
phaherpesvirus 1, cervid alphaherpesviruses 1 and 2 (Thiry et al.,
2007).
3.4. Virus inoculation in a seronegative buﬀalo
After virus inoculation, the buﬀalo showed transient serous nasal
discharge for 7 days. Fever was not recorded and rectal temperature
was about 38.2–38.5 °C. Virus was isolated from nasal swabs from day 2
to day 4 and from vaginal swabs from day 1 to day 5. PCR was positive
on nasal swabs and vaginal swab samples collected from day 1 to day 9
Table 1
Cross-serum neutralisation assay of diﬀerent categories of serum samples
against BoHV1 and BuHV1.
































gB-negative/gE-positive < 1:2 <1:2
< 1:2 <1:2
1:128 1:512




Viral isolation and PCR results on nasal and vaginal swab samples collected
from the buﬀalo 810 treated with sodium dexamethasone-21-phosphate.
Legend: NS= positivity in nasal swab samples; VS= positive in vaginal swab
samples; neg=negativity in both nasal and vaginal swab samples.
Days* Viral isolation PCR
5 neg NS, VS
6 VS NS, VS
7 NS, VS NS, VS
8 VS NS, VS
9 VS NS, VS
10 NS, VS NS, VS
11 VS NS, VS
12 VS NS, VS
13 NS, VS NS, VS
14 NS, VS NS, VS
15 neg NS, VS
*Days after the ﬁrst dexamethasone inoculation.
S. Preziuso et al. Veterinary Microbiology 221 (2018) 27–32
29
(Table 3).
3.5. Sequencing of the PCR products and phylogenetic analysis
Single PCRs with primers gB-1/gB-2, CR30/CR31 and CR52/CR54
gave expected products using DNA of infected cell cultures, swabs
collected from immunosuppressed buﬀalo and swabs of buﬀalo infected
with the virus IT08M134. Editing of UL27 overlapping sequences ob-
tained with primers gB-1/gB-2 and CR30/CR31 gave sequences about
680 bp long (GenBank accession numbers MH253680 and MH253681)
(Fig. S1). The sequences obtained from infected cells and from swab
samples were identical each others. BLAST analysis of the gB and gD
sequences showed higher identity with BuHV1 strain b6 (99% and
100% respectively). Phylogenetic analyses assessed the relationship
between the strain IT08M134 and other ruminant alphaherpesviruses
(Fig. 2a and b). IT08M134 clustered with BuHV1 strain b6, and it was
more related to BoHV5 than to BoHV1. By analyzing multiple nucleo-
tide sequence alignments in the UL27 partial sequence, strain
IT08M134 diﬀered from BuHV1 strain b6 by 3 out of 683 bases, from
BoHV5 strain SV507/99 by 14 bases and from BoHV1 strain Cooper by
28 bases (Fig. S1). Despite these substitutions, a few amino acid
changes were found. Indeed, there was only one amino acid substitu-
tion between IT08M134 and BuHV1 strain b6, 3 substitutions between
IT08M134 and BoHV5 strain SV507/99 and 9 substitutions between
IT08M134 and BoHV1 strain Cooper (Fig. S2). Only a partial compar-
ison was possible with an other Italian bubaline isolate (GenBank ac-
cession number AJ496607) because only a 414 bp sequence was
available. Strain IT08M134 diﬀered from this BuHV1 strain by 2 out of
338 nt, corresponding to only one amino acid substitution (Fig. S1 and
S2). UL6 sequence of IT08M134 was identical to BuHV1 strain b6, but
diﬀered from BoHV5 strain SV507/99 by 10 bases out of 558 and from
BoHV1 strain Cooper by 45 bases.
4. Discussion
IBR is a OIE-listed bovine disease causing signiﬁcant economic
losses in many countries. In European Union diﬀerent control measures
are adopted depending on the Member State on the basis of the pre-
valence of BoHV1 infection. Many countries allow and carry out vac-
cinations, while vaccination is prohibited in regions and countries
where the disease has been eradicated. Screening, surveillance, pre-
cautions at borders and culling of infected animals are often carried out
as eradication policy. In order to reduce the prevalence of IBR, the
European Community approved eradication programs to obtain BoHV1-
free holdings (Decision 2004/558/EC). Among others, speciﬁc ser-
ological tests are used to discriminate among uninfected, vaccinated
with a gE-deleted vaccine or infected animals. In particular, bovine
animals for breeding and production coming from Member States and
destined for intra-Community movements shall be gE- seronegative in
case of vaccinated animals, or seronegative for the entire BoHV1 in case
of unvaccinated animals. In the present study, a buﬀalo infected with
BuHV1 strain IT08M134 resulted gB-positive and gE-negative by com-
mercial ELISA tests, showing the same serological proﬁle of animals
vaccinated with a gE-deleted vaccine. Decision (2004/558/EC) does not
regard bubaline animals, however this study suggests that cattle in-
fected by this BuHV1 strain could result gB-positive by BoHV1 ELISA
tests. Although herpesviruses are generally species-speciﬁc, BuHV1 in-
fection in cattle and goats has been recently reported (Maidana et al.,
2016; Camero et al., 2017) and cross-infection cannot be ruled out.
The Directive 64/432/EEC includes also the species Bubalus bubalus
in the deﬁnition of bovine animals to manage animal health issues for
intra-Community trade. Considering that buﬀaloes infected with
BuHV1 can result gE-negative or gE-positive (Nogarol et al., 2014) and
that interspecies transmission is possible, diﬀerentiation between ani-
mals infected by BoHV1 or by BuHV1 could be diﬃcult by using tra-
ditional serological tests, thus the use of more speciﬁc tests should be
encouraged. The risk that cattle infected with this gE-negative BuHV1
strain result seropositive for BoHV1 by ELISA tests should be better
investigated because it could interfere with eradication programs ap-
proved by the European Union. The BuHV1 described in this study has
been isolated from nasal and vaginal swabs from an infected buﬀalo
after glucocorticoid treatment. The virus caused mild disease when
inoculated in an uninfected and unvaccinated buﬀalo; it is thus possible
that this virus spreads among animals without obvious clinical signs but
causing seroconversion, as reported also for other diﬀerent ruminant
species (Maidana et al., 2016; Camero et al., 2017).
Partial sequences of the genes encoding gB and gD were obtained
Fig. 1. Restriction endonuclease analysis patterns (enzymes BamHI and BstEII)
of bubaline herpesvirus 1 (BuHV1) isolated from experimentally reactivated
buﬀalo IT08M134. T7NS: day 7 nasal swab; T9VS: day 9 vaginal swab. The
proﬁles of the reactivated BuHV1 are clearly diﬀerent from BoHV1 subtype 1
(Lam strain) and subtype 2 (K22 strain) and the Italian BuHV1 b6. MW: mo-
lecular weight marker (base pairs).
Table 3
Viral isolation and PCR results on nasal and vaginal swab samples collected
from the buﬀalo inoculated intranasally with BuHV1 strain IT08M134. Legend:
NS=positivity in nasal swab samples; VS=positivity in vaginal swab samples;
neg=negativity in both nasal and vaginal swab samples.
Days* Viral isolation PCR
0 neg neg
1 VS NS, VS
2 NS, VS NS, VS
3 NS, VS NS, VS
4 NS, VS NS, VS
5 VS NS, VS
6 neg NS, VS
7 neg NS, VS
8 neg NS, VS







*Days after virus inoculation.
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from DNA of BuHV1 strain IT08M134, while none product was ob-
tained with primers speciﬁc for the gene encoding gE and described in
previous studies (Fuchs et al., 1999; De Carlo et al., 2004). Phylogenetic
tree based on gB and gD gene sequences clustered this strain with
BuHV1, and the highest homology was found with the prototype strain
b6, isolated in early 1970s in Australia from a buﬀalo. BuHV1 strain
IT08M134 was more closely related to BoHV-5 than to BoHV1, as
previously reported for other BuHV1 strains (De Carlo et al., 2004;
Thiry et al., 2007; Scheﬀer et al., 2017). In order to replicate previous
studies, sequencing of another DNA tract was done by primers IB1 and
IB3, which in bibliography are reported as speciﬁc for gI gene (Santurde
et al., 1996; De Carlo et al., 2004). However, after analysis of the
Fig. 2. Phylogenetic trees of ruminant alphaherpesvirus based on the nucleotide sequences of the gB (Fig. 2a) and gD (Fig. 2b) regions. Both trees were generated by
maximum likelihood method based on the Tamura 3-parameter model. A discrete Gamma distribution was used to model evolutionary rate diﬀerences among sites (5
categories (+G, parameter= 0.5486)). Evolutionary analyses were conducted in MEGA7. Suid Herpesvirus 1 was used as the outgroup.
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sequences obtained, IB1 and IB3 primers resulted speciﬁc for the gB
gene instead of the gI gene, and the sequence obtained was mostly
overlapped but shorter than the sequence obtained by gB-1/gB-2 pri-
mers.
In conclusion, this study describes a BuHV1 strain inducing a ser-
oconversion proﬁle which could interfere with IBR control and eradi-
cation programs. Indeed, animals infected from BuHV1 IT08M134 re-
sult gB-positive and gE-negative when tested by commercial ELISA
tests, showing a seroconversion proﬁle similar to animals vaccinated
with a BoHV1 gE-deleted vaccine. Further investigations should be
aimed at sequencing the full genome of this viral isolate and at evalu-
ating the susceptibility of other animal species.
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